A detailed history of Equitable Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Equitable Trust CO holds 84,970 shares of NVO stock, worth $9.15 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
84,970
Previous 86,078 1.29%
Holding current value
$9.15 Million
Previous $12.3 Million 17.65%
% of portfolio
0.69%
Previous 0.9%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$119.07 - $145.42 $131,929 - $161,125
-1,108 Reduced 1.29%
84,970 $10.1 Million
Q2 2024

Aug 01, 2024

BUY
$122.71 - $146.91 $317,573 - $380,203
2,588 Added 3.1%
86,078 $12.3 Million
Q1 2024

Apr 25, 2024

SELL
$102.11 - $135.92 $127,024 - $169,084
-1,244 Reduced 1.47%
83,490 $10.7 Million
Q4 2023

Jan 25, 2024

SELL
$87.78 - $105.45 $257,458 - $309,284
-2,933 Reduced 3.35%
84,734 $8.77 Million
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $4.44 Million - $9.75 Million
48,847 Added 125.83%
87,667 $7.97 Million
Q2 2023

Aug 09, 2023

SELL
$155.98 - $172.65 $52,097 - $57,665
-334 Reduced 0.85%
38,820 $6.28 Million
Q1 2023

May 08, 2023

SELL
$132.34 - $159.14 $521,419 - $627,011
-3,940 Reduced 9.14%
39,154 $6.23 Million
Q4 2022

Feb 21, 2023

SELL
$102.55 - $135.33 $472,345 - $623,329
-4,606 Reduced 9.66%
43,094 $5.83 Million
Q3 2022

Nov 03, 2022

SELL
$95.28 - $116.93 $535,664 - $657,380
-5,622 Reduced 10.54%
47,700 $4.75 Million
Q2 2022

Jul 15, 2022

BUY
$103.24 - $121.81 $1.35 Million - $1.6 Million
13,118 Added 32.63%
53,322 $5.94 Million
Q1 2022

May 06, 2022

BUY
$93.1 - $112.54 $3.23 Million - $3.9 Million
34,678 Added 627.54%
40,204 $4.47 Million
Q3 2021

Oct 26, 2021

SELL
$84.42 - $106.62 $675 - $852
-8 Reduced 0.14%
5,526 $530,000
Q2 2021

Aug 03, 2021

BUY
$67.66 - $84.76 $5,683 - $7,119
84 Added 1.54%
5,534 $464,000
Q1 2020

May 21, 2020

SELL
$49.46 - $64.78 $54,356 - $71,193
-1,099 Reduced 16.78%
5,450 $328,000
Q4 2019

Feb 18, 2020

BUY
$49.86 - $58.26 $1,445 - $1,689
29 Added 0.44%
6,549 $379,000
Q2 2019

Aug 16, 2019

BUY
$46.79 - $52.47 $701 - $787
15 Added 0.23%
6,520 $333,000
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $6,768 - $7,683
146 Added 2.3%
6,505 $340,000
Q4 2018

Feb 22, 2019

BUY
$41.54 - $47.25 $27,541 - $31,326
663 Added 11.64%
6,359 $293,000
Q3 2018

Nov 15, 2018

SELL
$46.76 - $51.24 $2,384 - $2,613
-51 Reduced 0.89%
5,696 $269,000
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $254,534 - $289,763
5,747 New
5,747 $265,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Equitable Trust CO Portfolio

Follow Equitable Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.